Durvalumab vs Irbesartan

## Durvalumab vs Irbesartan: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Irbesartan**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Irbesartan — 11-15 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Irbesartan — C25H28N6O.

**Molecular Weight**: Durvalumab — N/A; Irbesartan — 428.5320 g/mol.

**Type**: Durvalumab — Antibody; Irbesartan — Small molecule.